Episode #55 - Epilepsy Drug Development: Clinical Trials featuring Dr. Kelly Knupp

Seizing Life > Epilepsy Drug Development: Clinical Trials

The multi-step process of developing a new epilepsy drug can take many years and requires a small army of researchers, chemists, scientists, physicians, and data analysts. But ultimately it’s the human volunteers and their responses to the drug that will determine if a new medication wins FDA approval. Clinical trials are the first time that the drug being evaluated is given to human volunteers. They are conducted in multiple phases and focus on safety, effectiveness, and potential side effects. Each phase of the clinical trial is carefully designed and rigorously regulated by the FDA to ensure the well-being of the volunteers and the collection of unbiased data by researchers. It’s a thoughtful and thorough process that holds the promise of transforming the lives of those with epilepsy.

In the second part of our 4-part series exploring the drug development process and clinical trial participation, we speak with Dr. Kelly Knupp, Associate Research Director of the Neuroscience Institute and Director of the Dravet Program at Children’s Hospital Colorado. Dr. Knupp provides a comprehensive explanation of human clinical trials in layman’s terms. She details the procedures and goals of each phase of the process, explains trial terminology, outlines key personnel and responsibilities, and describes the FDA requirements for new drug approval. It’s everything you want to know about clinical trials but didn’t know how to ask.

Download Audio

Want to download this episode? Fill out the form below and enjoy the podcast any time you’d like!

    Back to Episode Download PDF

    Epilepsy Drug Development: Clinical Trials - Transcript

    Related Episodes

    featured episode
    Epilepsy and AdvocacyEpilepsy Research
    May 31, 2023

    #117 Epilepsy Researcher Compounds Lab Work with Fundraising

    Guest: Dr. Patrice Jackson-Ayotunde

    This week on Seizing Life® Dr. Patrice Jackson-Ayotunde discusses her 20+ years of epilepsy drug research and her decade-long epilepsy fundraising efforts.

    featured episode
    Epilepsy and AdvocacyEpilepsy Research
    March 22, 2023

    #112 From Desperation to Hope: The Founding and Future of CURE Epilepsy

    Guest: Susan Axelrod and Barbara Kelly

    This week on Seizing Life Susan Axelrod, CURE Epilepsy founder, and Barbara Kelly, the founding Research Chair, discuss the past, present, and future of the organization and epilepsy research.

    featured episode
    Epilepsy ResearchLiving with Epilepsy
    November 16, 2022

    #103 The Impact of Epilepsy and Seizures on Cognition and Memory

    Guest: Dr. Alice Lam

    This week on Seizing Life® we speak with neurologist Dr. Alice Lam about the potential impacts of seizures on cognition and memory. We discuss both the possible short-term and long-term effects of epilepsy on cognition and memory, and the differering ways that seizures may impact children, adults, and aging adults.